Latest News

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibur ridiculus mus.

News

Lorem ipsum dolor sit amet, consectetlit. Aenean eget dolor.

Prescriptions jump for EpiPen alternatives

Concerns over the soaring cost of Mylan's (NASDAQ:MYL) EpiPen,…